We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Influenza vaccines marketed in the UK for 2024 to 2025, including ovalbumin content.
Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.
Patient group direction (PGD) template for administering inactivated influenza vaccine in accordance with national seasonal flu vaccination programme.
Information for health professionals on childhood immunisations.
PGD template to support the administration of live attenuated influenza vaccine (Fluenz Trivalent®) in accordance with the national seasonal influenza vaccination programme.
Guidance for people aged 12 and over whose immune system means they are at higher risk of serious illness if they become infected with COVID-19.
This protocol is for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza vaccination programme.
Hepatitis B immunisation information for public health professionals.
Health protection teams (HPT) provide specialist public health advice and operational support to NHS, local authorities and other agencies.
Patient Group Direction (PGD) template to support the national vaccination programme for pregnant women to protect infants and older adults aged 75 to 79 years old.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
This explains the importance of the influenza (flu) vaccination this winter: 2024 to 2025.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Guidance for healthcare practitioners on the national influenza immunisation programme 2024 to 2025.
Marburg virus is a filovirus which, along with Ebola virus, can cause a severe and often fatal viral haemorrhagic fever (VHF).
Information for public health professionals on immunisation.
Tetanus immunisation information for public health professionals, including updates.
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).